STX6 and hepatocellular carcinoma: Argonaute-CLIP sequencing in humans and mice identified novel miR-122 targets, such as B cell lymphoma 9 (BCL9), solute carrier family 25 member 2 (SLC52A2) and syntaxin 6 (STX6), which could predict survival in HCC patients [85].